pharma · Netherton Syndrome · QNRX
Quoin Pharmaceuticals
Quoin Pharmaceuticals,
Quoin Pharmaceuticals is a pharma organization headquartered in Ashburn, USA. It trades on NYSE under ticker QNRX. Primary therapeutic focus areas include Netherton Syndrome. NovaPharmaNews links 3 clinical program(s), 0
Company details
- Status
- Public
- HQ
- Ashburn, USA
- Founded
- 2018
- Employees
- 9
- Programs
- 3
- Drugs
- 0
- Patents
- 0
Quick answer
Quoin Pharmaceuticals is a pharma organization headquartered in Ashburn, USA. It trades on NYSE under ticker QNRX. Primary therapeutic focus areas include Netherton Syndrome. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (3).
Company snapshot
Founded in 2018, Quoin is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities, and care teams. Quoin’s innovative pipeline comprises three products that collectively have the potential to target a broad number of r
- 3 active pipeline program(s) linked via ClinicalTrials.gov.
- 3 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for Quoin Pharmaceuticals. Not investment advice.
Catalysts
Upcoming readouts, regulatory dates, and congress activity.
- trial_data
Japan Grants Orphan Status to QRX003 for Netherton Syndrome: Implications for Pharma Teams
Recent coverage
Top assets
Lead pipeline drugs
- Phase 3
- Phase 3
- Phase 3
Active clinical programs
- Phase 3
- Phase 3
- Phase 3
Momentum
Proprietary activity score for Quoin Pharmaceuticals.
2 active signals
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Recent activity
Latest pipeline, patent, and corporate events for Quoin Pharmaceuticals.
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Quoin Pharmaceuticals?
-
Is Quoin Pharmaceuticals publicly traded?
-
What drugs does Quoin Pharmaceuticals develop or market?
-
What are the latest developments for Quoin Pharmaceuticals?
-
What therapeutic areas does Quoin Pharmaceuticals focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.